Đang chuẩn bị liên kết để tải về tài liệu:
Decision-analytic evaluation of the comparative effectiveness and cost-effective of strategies to prevent breast and ovarian cancer in German women with BRCA-1/2 mutations

Women with inherited mutations in the BRCA1 or BRCA2 genes have increased lifetime risks for developing breast and/or ovarian cancer and may develop these cancers around the age of 30 years. Therefore, prevention of breast and ovarian cancer in these women may need to start relatively early in life. |